Dalar Levent, Kosar Filizs, Eryuksel Emel, Karasulu Levent, Altin Sedat
Interventional Pulmonology Unit, Yedikule Chest Diseases and Thoracic Surgery Teaching Hospital, Istanbul, Turkey.
Ann Thorac Cardiovasc Surg. 2013;19(2):140-3. doi: 10.5761/atcs.cr.11.01760. Epub 2012 Jun 29.
Tuberculosis may be complicated with empyema and fistula in patients with cellular immune deficiency. The case presented was a 39-year-old male patient with diagnosis of rheumatoid arthritis developed hydropneumothorax while taking steroid and immunosuppressive treatment and examination of pleural fluid revealed acid-fast bacilli. The patient was admitted to the intensive care unit due to respiratory failure and underwent bronchoscopic examination due to air leakage. The right middle lobe was obliterated by using an endobronchial Watanabe Spigot (EWS), and the amount of leakage decreased considerably after the procedure. On day 7, chest tube drainage was removed, and empyema was drained with a Pezzer drain. On day 50, upon the cessation of empyema drainage, spigots were removed with rigid and flexible bronchoscope. In conclusion, EWS use in the treatment of bronchopleural fistula is an effective, safe and a reversible procedure.
在细胞免疫缺陷患者中,肺结核可能并发脓胸和瘘管。本文介绍的病例是一名39岁男性患者,诊断为类风湿性关节炎,在接受类固醇和免疫抑制治疗时发生气胸,胸腔积液检查发现抗酸杆菌。患者因呼吸衰竭入住重症监护病房,因漏气接受支气管镜检查。使用支气管内渡边套管(EWS)闭塞右中叶,术后漏气量显著减少。第7天,拔除胸管,用Pezzer引流管引流脓胸。第50天,在停止脓胸引流后,用硬支气管镜和软支气管镜取出套管。总之,EWS用于治疗支气管胸膜瘘是一种有效、安全且可逆的方法。